The role of amrinone in weaning patients from hypothermic cardiopulmonary bypass

Category Primary study
JournalCanadian Journal of Anaesthesia
Year 1988
The need exists for a cardiotonic drug which will enhance cardiac performance and facilitate weaning from CPB without detrimental effect to the heart. Amrinone, a relatively new, non-glycoside, non-catecholamine agent with both positive inotropic and vasodilator effects may be such a drug. This study was undertaken to determine the efficacy of amrinone vs placebo in facilitating weaning from cardiopulmonary bypass.
Epistemonikos ID: 58fc4790274428aa87dc884796fd98ec80aa3a97
First added on: Feb 03, 2025